Vitamin C (Liposomal or Intravenous) Can Save Your Life
How did the Chinese effectively end the COVID-19 pandemic in April 2020?
"Analysis of 437 human blood samples has shown that when the plasma-reduced ascorbic acid level falls below 1 mg/100 ml, the whole blood histamine level increases exponentially as the ascorbic acid level decreases. When the ascorbic acid level falls below 0.7 mg/100 ml, there is a highly significant increase in the blood histamine level. Oral administration of ascorbic acid (1 g daily for 3 days) to 11 selected volunteers resulted in a reduction of the blood histamine level in every instance."
Histamine and ascorbic acid in human blood
https://pubmed.ncbi.nlm.nih.gov/7365537/
VITAMIN C
With the exception of a statistical anomoly that occurred on April 17, 2020, China had a modest number of deaths in January, February and March of 2020, and they have pretty much reduced their deaths since then to nearly zero.
Scroll down to learn one of the many reasons for their success.
Look at what they recommended way back on March 3, 2020.
Scroll down to learn one of the many reasons for their success.
Look at what they recommended way back on March 3, 2020.
CHINA:
Please remember that China
has 3-4 times as many people
as the United States.
UNITED STATES:
WHY?
China gives their COVID-19 patients adequate amounts of intravenous (IV) Vitamin C to keep them alive.
"The government of Shanghai, China has announced its official recommendation that COVID-19 should be treated with high amounts of intravenous vitamin C. (1) Dosage recommendations vary with severity of illness, from 50 to 200 milligrams per kilogram body weight per day.
These dosages are approximately 4g to 20g for an adult, administered by IV. This specific method of administration is important, says intravenous therapy expert Atsuo Yanagisawa, MD, PhD, because vitamin C's effect is at least ten times more powerful by IV than if taken orally.
Dr. Yanagisawa is president of the Tokyo-based Japanese College of Intravenous Therapy. He says, "Intravenous vitamin C is a safe, effective, and broad-spectrum antiviral."
Richard Z. Cheng, MD, PhD, a Chinese-American specialist physician, has been working closely with medical and governmental authorities throughout China. He has been instrumental in facilitating at least three Chinese clinical IV vitamin C studies now underway. Dr. Cheng is presently in Shanghai continuing his efforts to encourage still more Chinese hospitals to implement vitamin C therapy incorporating high oral doses as well as C by IV.
Dr. Cheng and Dr. Yanagisawa both recommend oral vitamin C for prevention of COVID-19 infection.
An official statement from Xi'an Jiaotong University Second Hospital (2) reads:"
These dosages are approximately 4g to 20g for an adult, administered by IV. This specific method of administration is important, says intravenous therapy expert Atsuo Yanagisawa, MD, PhD, because vitamin C's effect is at least ten times more powerful by IV than if taken orally.
Dr. Yanagisawa is president of the Tokyo-based Japanese College of Intravenous Therapy. He says, "Intravenous vitamin C is a safe, effective, and broad-spectrum antiviral."
Richard Z. Cheng, MD, PhD, a Chinese-American specialist physician, has been working closely with medical and governmental authorities throughout China. He has been instrumental in facilitating at least three Chinese clinical IV vitamin C studies now underway. Dr. Cheng is presently in Shanghai continuing his efforts to encourage still more Chinese hospitals to implement vitamin C therapy incorporating high oral doses as well as C by IV.
Dr. Cheng and Dr. Yanagisawa both recommend oral vitamin C for prevention of COVID-19 infection.
An official statement from Xi'an Jiaotong University Second Hospital (2) reads:"
References
1. https://mp.weixin.qq.com/s/bF2YhJKiOfe1yimBc4XwOA
2. http://2yuan.xjtu.edu.cn/Html/News/Articles/21774.html
1. https://mp.weixin.qq.com/s/bF2YhJKiOfe1yimBc4XwOA
2. http://2yuan.xjtu.edu.cn/Html/News/Articles/21774.html
Vitamin C Treatment of COVID-19: Case Reports
September 27, 2020
by Andrew W. Saul and Doctor X
"Many years ago, when I was first starting out in the natural healing field, a physician said to me, “You are lucky. You have no license to lose.” When doctors are to be silenced, they are simply threatened with loss of their license to practice medicine. State licensing board attacks on physicians are private and administrative. Such proceedings never get to open court; they never get to a jury. It is all behind closed doors. The most effective instrument of compliance is a bureaucracy, not the judiciary.
And it works.
That is why I am publishing this series of 22 case reports from a board-certified specialist but without revealing the doctor’s name. I want this physician to keep being able to practice and heal sick people.
Read them and decide for yourself about the merits of vitamin C against COVID-19."
September 27, 2020
by Andrew W. Saul and Doctor X
"Many years ago, when I was first starting out in the natural healing field, a physician said to me, “You are lucky. You have no license to lose.” When doctors are to be silenced, they are simply threatened with loss of their license to practice medicine. State licensing board attacks on physicians are private and administrative. Such proceedings never get to open court; they never get to a jury. It is all behind closed doors. The most effective instrument of compliance is a bureaucracy, not the judiciary.
And it works.
That is why I am publishing this series of 22 case reports from a board-certified specialist but without revealing the doctor’s name. I want this physician to keep being able to practice and heal sick people.
Read them and decide for yourself about the merits of vitamin C against COVID-19."
- 47 y/o female with PMH (previous medical history) of anxiety, depression, hypothyroid presented with 11 day history of fatigue, dry cough, sore throat, muscle aches, SOB (shortness of breath), abdominal pain and loss of appetite. She tested positive for COVID and received 3 consecutive days of IV Vitamin C 25 grams. By day 3, fatigue, cough, SOB and appetite all improved.
- 63 y/o AAF (African American female) with PMH of sickle cell trait presented with 10 day history of fatigue, dry cough, sore throat, fever, muscle aches, congestion, headache, SOB, nausea. Patient was COVID positive and received 3 consecutive days of IV Vitamin C 7.5/25/25 grams. By day 3, fever and headache resolved. Fatigue, cough, aches, and SOB all significantly improved.
- 35 y/o WM (white male) with PMH of HTN (hypertension, i.e. high blood pressure), high cholesterol, sleep apnea presented with 1 week of cough, DOE (dyspnea on exertion, i.e. gets out of breath with exercise), fatigue. Patient was COVID positive and received 3 consecutive days of IV Vitamin C 25 grams. By day 3, fever resolved, fatigue was improving, and cough and DOE significantly improved.
- 36 y/o WM COVID positive with no PMH presented with 4 day history of dry cough, chills/sweats, SOB and headache. Patient received 3 days of 25 grams of IV Vitamin C. By day 3, cough was still present and patient did have a loss of taste and smell but otherwise had no complaints.
- 66 y/o male COVID positive with PMH of asthma, DM (diabetes) HTN presented to the clinic with 9 days of fatigue, cough, body aches, sinus congestion, HA (headache), SOB, diarrhea, and loss of appetite. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of day 3, fatigue, SOB, cough improved slightly, and his aches, congestion, diarrhea and HA resolved.
- 30 y/o AAM (African American male) with PMH of HTN and DM presented with 2 week history of fatigue, sinus congestion, productive cough, SOB and loss of appetite. He tested positive for COVID the day before arriving to our clinic. Patient received 3 consecutive days of IV Vitamin C 25 grams. By day 3, fatigue and sinus congestion improved. His appetite was back to normal. Cough and SOB significantly improved and he was able to walk up stairs again.
- 19 year old WF (white female) with no past medical history. She tested positive for COVID. Symptoms of fatigue and sinus congestion have been present for 1 day. She completed 3 days of vitamin C IV, 25 grams. On day 3 she had no symptoms except for slight loss in sense of smell and taste.
- A 19 year old WM with a history of asthma and pertussis as a child. He tested positive for COVID. He has been having symptoms of fatigue, dry cough, sore throat, muscle ache , sinus congestion, headache, nausea, vomiting, diarrhea and loss of appetite for 4-5 days prior to visit. He completed 3 days of vitamin C IV 25. By day 3 he had no symptoms and felt great.
- 67 y/o WM with PMH of diabetes and hypothyroid presented with symptoms for 1 month including fever, fatigue, cough, body aches and headache. He tested positive for COVID 1 week prior to his arrival to the clinic. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, his fever, headache and body aches resolved, and fatigue and cough significantly improved.
- 60 y/o male with PMH of DM2 (diabetes type 2) presented with symptoms for 1 week. COVID positive. Symptoms included fever, fatigue, dry cough, muscle aches, congestion, headache, SOB, abdominal pain, and nausea. He also had chills/sweats and loss of taste and smell. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, his cough was slightly improved, headache was resolved, SOB improved, nausea improved, chills and sweats resolved, and taste and smell were coming back.
- 59 y/o AAM with PMH of HTN and COVID positive presented with symptoms for 3 weeks. Included fever, fatigue, headache, SOB, chills and sweats. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, fever resolved, fatigue and SOB and cough were all improving.
- 34 y/o WF with no PMH but COVID positive presented with 4 day history of back pain and HA that did resolve prior to her first IV. She completed 3 days of IV Vitamin C 25 grams and had no symptoms on day 3.
- 43 y/o AAF with PMH of endometriosis fibroids and b/l PE (bilateral pulmonary embolism, i.e. blood clots in lungs) and COVID positive presented with symptoms for 8 days. These included fatigue, dry cough, sore throat, mild SOB, diarrhea, chest pain with coughing. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, fatigue, cough and sore throat and chest pain resolved and patient reported feeling much better overall.
- 38 y/o AAF with PMH of ADHD and COVID positive presented with 2 days of fatigue. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, her fatigue was improved and patient had no other symptoms.
- 45 y/o AAF with PMH of hypercholesterolemia and CVA (cardiovascular attack i.e. stroke) and COVID positive presented with symptoms for 2.5 weeks. These included fatigue, cough, HA, SOB, nausea, chest tightness, loss of appetite. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, patient reported improvement in fatigue, cough, SOB. Nausea resolved. Chest tightness was minimal.
- 41 y/o WM with no PMH and COVID positive presented with 9 days of fatigue, dry cough, and headache. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, fatigue was improving, cough was minimal, and headache had resolved.
- A 67 y/o female with PMH of high cholesterol and COVID positive presented with 1 week of symptoms including fatigue, nausea, fever, and poor appetite. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, fever resolved and fatigue was improving.
- A 65 y/o female with PMH of Hashimoto's disease, depression, and COVID positive presented with 2 weeks of fatigue, chest tightness, and poor appetite. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, chest tightness resolved and fatigue was improving and appetite was improving.
- 31 y/o female with PMH of asthma, anemia, and allergies, and COVID positive presented with 1 week of fatigue, dry cough, congestion, and loss of smell. Patient received 3 consecutive days of IV Vitamin C 25 grams. By the end of the 3rd day, smell had returned, appetite was much improved, congestion resolved, and fatigue resolved. Cough also resolved.
- A 67 year old WM with past medical history of kidney stones. He tested positive for COVID. He started with symptoms of fever and fatigue. He completed 3 days of vitamin C IV, 25 grams. By day 3 symptoms had improved and he was back to 95%.
- A 38 year old WF with no past medical history. She tested positive for COVID. She started with symptoms of fatigue, dry cough, sore throat, muscle ache, sinus congestion and headache that have been present for 2 days prior to her appointment. She completed 3 days of vitamin C IV 25 grams. By day 3 She felt much better and only had a mild sore throat and PND (Paroxysmal nocturnal dyspnea, i.e. difficulty breathing at night).
- A 42 year old WM with no past medical history. Tested positive for COVID. Symptoms started 10 days ago. He started with fever and body aches. He also developed nasal congestion, dizziness, PND and difficulty taking deep breaths. He completed 3 days of vitamin C IV 25. By day 3 he felt much better. He still had some fatigue and mild congestion, but overall he felt much better. He is now able to take deep breaths without problems.
"Virtually all the above COVID patients received 25g of vitamin C intravenously for three days. They all recovered, and many recovered with spectacular rapidity.
This information is being censored by the commercial news media. It is being kept off Facebook, Twitter, Google and YouTube. That is why OMNS has issued this release. As A. J. Liebling said decades ago, “Freedom of the press is guaranteed only to those who own one.”
Withholding vitamin C treatment information from the public withholds it from the patient. We accuse the media of negligence. They can correct this at any time.
Until they do, we will do it for them."
This information is being censored by the commercial news media. It is being kept off Facebook, Twitter, Google and YouTube. That is why OMNS has issued this release. As A. J. Liebling said decades ago, “Freedom of the press is guaranteed only to those who own one.”
Withholding vitamin C treatment information from the public withholds it from the patient. We accuse the media of negligence. They can correct this at any time.
Until they do, we will do it for them."
Many thanks to Colleen Huber, NMD for the information below...
At the Ruijing Hospital in Shanghai, 50 COVID-19 patients were treated with vitamin C. Their hospital stays were 5 days shorter than those COVID-19 patients not treated with Vitamin C. There were no deaths in the Vitamin C group, and no significant side effects were noted either. In the other group of COVID-19 patients, those who did not receive vitamin C, there were 3 deaths. (25)
Dr. Zhiyong Peng conducted the first clinical trial of high-dose intravenous vitamin C with COVID19 patients at Wuhan University in Wuhan, China. His findings were that this treatment of COVID-19 patients reduced their inflammation significantly, and that it reduced their stays in ICU and hospitals. (26) (27)
Vitamin C should be no surprise as an addition to the list of nutrients that provide life-saving help against COVID-19. Dr. Fred Klenner wrote in 1948 about use of intravenous and intramuscular use of vitamin C against viral pneumonia: “In almost every case the patient felt better within an hour after the first injection and noted a very definite change after two hours.” And “three to seven injections gave complete clinical and x-ray response in all of our [42] cases.” (28)
Dr. Thomas Levy writes: “As the ultimate virucide, vitamin C has been documented to inactivate or destroy every virus against which it was tested in vitro. Similarly, vitamin C has consistently resolved nearly all acute viral infections in patients treated with sufficient doses.” He discusses these clinical findings extensively here (29) and here. (30)
Vitamin C has numerous well-studied and documented mechanisms against viruses. Perhaps the most important of these is the production of Type I interferons. (31) This in turn upregulates natural killer cells and cytotoxic T-lymphocytes for anti-viral activity. (32) However, it has been shown to simply inactivate both RNA and DNA viruses. (33) It also detoxifies viral products that are associated with inflammation and pain. High dose vitamin C and oral doses over 3 grams are established to both prevent and treat a variety of viral infections. (34) (35)
25 R Cheng. COVID-19, vitamin C, vaccine and integrative medicine. Apr 16 2020. Cheng Integrative Health Center Blog.
https://www.drwlc.com/blog/category/covid-19-vit-c-and-integrative-medicine/
26 Z Peng interview with R Cheng. Wuhan University. The original video was removed by YouTube. However, the discussion continues on in this video, among several clinicians, in which they discuss dosing, frequency and morbidity of the patients treated. A very wide range of doses in intravenous vitamin C was used.
https://youtu.be/ZfHj9FeVAJM
27 R Cheng. Video conference with Dr ZY Peng, one of the world’s first high-dose IVC trials. Apr 16 2020. Cheng Integrative Health Center Blog.
https://www.drwlc.com/blog/category/covid-19-vit-c-and-integrative-medicine/
28 F Klenner. Virus pneumonia and its treatment with vitamin C. Read by title to the Tri-State Medical Association of the Carolinas and Virginia, and in Southern Med and Surg.110(2): 36-38. Feb 1948.
https://www.seanet.com/~alexs/ascorbate/194x/klenner-fr-southern_med_surg-1948-v110-n2-p36.htm
29 Levy T (2011) Primal Panacea, Henderson, NV: MedFox Publishing. ISBN-13: 978-0983772804.
30 Levy T (2002) Curing the Incurable. Vitamin C, Infectious Diseases, and Toxins, Henderson, NV: MedFox Publishing. ISBN-13: 978-0977952021
31 Y Kim et al. Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-a/b at the initial stage of influenza A virus (H3N2) infection. Immune Netw. Apr 2020. 13(2)70-4. doi: 10.4110/in.2013.13.2.70
https://pubmed.ncbi.nlm.nih.gov/23700397/
32 S Madhusudana, et al. In vitro inactivation of the rabies virus by ascorbic acid. Int J Infectious Dis. Jan 2004. 8(1):21-25. https://pubmed.ncbi.nlm.nih.gov/14690777/
33 R Jariwalla et al. Antiviral and immunomodulatory activities of ascorbic acid. Subcell Biochem. 1996;25:213-31.
https://pubmed.ncbi.nlm.nih.gov/8821976/
34 A Carr et al. Vitamin C and Immune Function. Nutrients. Nov 2017; 9(11): 1211-1236.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707683/
35 M Gonzalez et al. High dose vitamin C and influenza: A case report. 2018. J Orthomol Medicine. 33(3).
https://isom.ca/article/high-dose-vitamin-c-influenza-case-report/
Dr. Zhiyong Peng conducted the first clinical trial of high-dose intravenous vitamin C with COVID19 patients at Wuhan University in Wuhan, China. His findings were that this treatment of COVID-19 patients reduced their inflammation significantly, and that it reduced their stays in ICU and hospitals. (26) (27)
Vitamin C should be no surprise as an addition to the list of nutrients that provide life-saving help against COVID-19. Dr. Fred Klenner wrote in 1948 about use of intravenous and intramuscular use of vitamin C against viral pneumonia: “In almost every case the patient felt better within an hour after the first injection and noted a very definite change after two hours.” And “three to seven injections gave complete clinical and x-ray response in all of our [42] cases.” (28)
Dr. Thomas Levy writes: “As the ultimate virucide, vitamin C has been documented to inactivate or destroy every virus against which it was tested in vitro. Similarly, vitamin C has consistently resolved nearly all acute viral infections in patients treated with sufficient doses.” He discusses these clinical findings extensively here (29) and here. (30)
Vitamin C has numerous well-studied and documented mechanisms against viruses. Perhaps the most important of these is the production of Type I interferons. (31) This in turn upregulates natural killer cells and cytotoxic T-lymphocytes for anti-viral activity. (32) However, it has been shown to simply inactivate both RNA and DNA viruses. (33) It also detoxifies viral products that are associated with inflammation and pain. High dose vitamin C and oral doses over 3 grams are established to both prevent and treat a variety of viral infections. (34) (35)
25 R Cheng. COVID-19, vitamin C, vaccine and integrative medicine. Apr 16 2020. Cheng Integrative Health Center Blog.
https://www.drwlc.com/blog/category/covid-19-vit-c-and-integrative-medicine/
26 Z Peng interview with R Cheng. Wuhan University. The original video was removed by YouTube. However, the discussion continues on in this video, among several clinicians, in which they discuss dosing, frequency and morbidity of the patients treated. A very wide range of doses in intravenous vitamin C was used.
https://youtu.be/ZfHj9FeVAJM
27 R Cheng. Video conference with Dr ZY Peng, one of the world’s first high-dose IVC trials. Apr 16 2020. Cheng Integrative Health Center Blog.
https://www.drwlc.com/blog/category/covid-19-vit-c-and-integrative-medicine/
28 F Klenner. Virus pneumonia and its treatment with vitamin C. Read by title to the Tri-State Medical Association of the Carolinas and Virginia, and in Southern Med and Surg.110(2): 36-38. Feb 1948.
https://www.seanet.com/~alexs/ascorbate/194x/klenner-fr-southern_med_surg-1948-v110-n2-p36.htm
29 Levy T (2011) Primal Panacea, Henderson, NV: MedFox Publishing. ISBN-13: 978-0983772804.
30 Levy T (2002) Curing the Incurable. Vitamin C, Infectious Diseases, and Toxins, Henderson, NV: MedFox Publishing. ISBN-13: 978-0977952021
31 Y Kim et al. Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-a/b at the initial stage of influenza A virus (H3N2) infection. Immune Netw. Apr 2020. 13(2)70-4. doi: 10.4110/in.2013.13.2.70
https://pubmed.ncbi.nlm.nih.gov/23700397/
32 S Madhusudana, et al. In vitro inactivation of the rabies virus by ascorbic acid. Int J Infectious Dis. Jan 2004. 8(1):21-25. https://pubmed.ncbi.nlm.nih.gov/14690777/
33 R Jariwalla et al. Antiviral and immunomodulatory activities of ascorbic acid. Subcell Biochem. 1996;25:213-31.
https://pubmed.ncbi.nlm.nih.gov/8821976/
34 A Carr et al. Vitamin C and Immune Function. Nutrients. Nov 2017; 9(11): 1211-1236.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707683/
35 M Gonzalez et al. High dose vitamin C and influenza: A case report. 2018. J Orthomol Medicine. 33(3).
https://isom.ca/article/high-dose-vitamin-c-influenza-case-report/
REFERENCES:
Vitamin C Treatment of COVID-19: Case Reports
September 27, 2020
by Andrew W. Saul and Doctor X
http://orthomolecular.org/resources/omns/v16n47.shtml
September 27, 2020
by Andrew W. Saul and Doctor X
http://orthomolecular.org/resources/omns/v16n47.shtml
Vitamin C for the Prevention and Treatment of Coronavirus
July 7, 2020
by Patrick Holford
http://orthomolecular.org/resources/omns/v16n36.shtml
Smothering the Fire: How Vitamin C Can Stop Viral Infections Quickly
May 28, 2020
by Tom Taylor
http://orthomolecular.org/resources/omns/v16n30.shtml
May 28, 2020
by Tom Taylor
http://orthomolecular.org/resources/omns/v16n30.shtml
Vitamin C and Coronavirus: Not a Vaccine; Just a Humble Cure
May 4, 2020
by William F. Simmons and Robert G. Smith, PhD
http://orthomolecular.org/resources/omns/v16n28.shtml
May 4, 2020
by William F. Simmons and Robert G. Smith, PhD
http://orthomolecular.org/resources/omns/v16n28.shtml
Vitamin C Evidence for Treating Complications of COVID-19 and other Viral Infections
April 23, 2020
by Magnus P. F. Rasmussen
http://orthomolecular.org/resources/omns/v16n25.shtml
Rationale for Vitamin C Treatment of COVID-19 and Other Viruses
April 3, 2020
by the Orthomolecular Medicine News Service Editorial Review Board
http://orthomolecular.org/resources/omns/v16n21.shtml
Rationale for Vitamin C Treatment of COVID-19 and Other Viruses
April 3, 2020
by the Orthomolecular Medicine News Service Editorial Review Board
http://orthomolecular.org/resources/omns/v16n21.shtml
Published Research and Articles on Vitamin C as a Consideration for Pneumonia, Lung Infections, and the Novel Coronavirus (SARS-CoV-2/COVID-19)
March 22, 2020
by Graham Player, PhD, Andrew W. Saul, Damien Downing, MBBS, MRSB and Gert Schuitemaker, PhD
http://orthomolecular.org/resources/omns/v16n20.shtml
High-dose Intravenous Vitamin C Treatment for COVID-19
March 21, 2020
by Adnan Erol, M.D.
http://orthomolecular.org/resources/omns/v16n19.shtml
Successful High-Dose Vitamin C Treatment of Patients with Serious and Critical COVID-19 Infection
March 18, 2020
by Richard Cheng, MD, PhD
http://orthomolecular.org/resources/omns/v16n18.shtml
Vitamin C Saves Wuhan Family from COVID-19
March 5, 2020
by Richard Cheng, M.D., Ph.D.
http://orthomolecular.org/resources/omns/v16n17.shtml
Shanghai Government Officially Recommends Vitamin C for COVID-19
March 3, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n16.shtml
News Media Attacks Vitamin C Treatment of COVID-19 Coronavirus Yet Ascorbate is a Proven, Powerful Antiviral
March 1, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n15.shtml
Vitamin C and COVID-19 Coronavirus
February 28, 2020
by Damien Downing, MBBS, MRSB and Gert Schuitemaker, PhD
http://orthomolecular.org/resources/omns/v16n14.shtml
TONS OF VITAMIN C TO WUHAN
China Using Vitamin C Against COVID
February 23, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n13.shtml
China Using Vitamin C Against COVID
February 23, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n13.shtml
Three Intravenous Vitamin C Research Studies Approved for Treating COVID-19
February 21, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n12.shtml
Early Large Dose Intravenous Vitamin C is the Treatment of Choice for 2019-nCov Pneumonia
February 16, 2020
Richard Z Cheng, MD, PhD; Hanping Shi, MD, PhD; Atsuo Yanagisawa, MD, PhD; Thomas Levy, MD, JD; Andrew Saul, PhD.
http://orthomolecular.org/resources/omns/v16n11.shtml
Coronavirus Patients in China to be Treated with High-Dose Vitamin C
February 13, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n10.shtml
VITAMIN C AND ITS APPLICATION TO THE TREATMENT OF nCoV CORONAVIRUS
How Vitamin C Reduces Severity and Deaths from Serious Viral Respiratory Diseases
February 10, 2020
by Andrew W. Saul, Editor
http://orthomolecular.org/resources/omns/v16n09.shtml
How Vitamin C Reduces Severity and Deaths from Serious Viral Respiratory Diseases
February 10, 2020
by Andrew W. Saul, Editor
http://orthomolecular.org/resources/omns/v16n09.shtml
Hospital-based Intravenous Vitamin C Treatment for Coronavirus and Related Illnesses
February 2, 2020
by Andrew W. Saul and Atsuo Yanagisawa, MD, PhD
http://orthomolecular.org/resources/omns/v16n07.shtml
February 2, 2020
by Andrew W. Saul and Atsuo Yanagisawa, MD, PhD
http://orthomolecular.org/resources/omns/v16n07.shtml
Nutritional Treatment of Coronavirus
January 30, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n06.shtml
Vitamin C Protects Against Coronavirus
Orthomolecular Medicine News Service
Jan 26, 2020
by Andrew W. Saul
http://orthomolecular.org/resources/omns/v16n04.shtml
RECENT ARTICLES:
https://www.savannahnow.com/news/20201013/georgia-university-says-lack-of-vitamin-c-could-play-role-in-covid-19-and-longterm-effects
